- Title
- Long term risk of distant metastasis in women with non-metastatic breast cancer and survival after metastasis detection: a population-based linked health records study
- Creator
- Lord, Sarah (Sally); Daniels, Benjamin; Kiely, Belinda E.; O'Connell, Dianne L.; Beith, Jane; Pearson, Sallie; Chiew, Kim-Lin; Bulsara, Max K.; Houssami, Nehmat
- Relation
- Medical Journal of Australia Vol. 217, Issue 8, p. 402-409
- Publisher Link
- http://dx.doi.org/10.5694/mja2.51687
- Publisher
- John Wiley & Sons
- Resource Type
- journal article
- Date
- 2022
- Description
- Objectives: To estimate the long term risk of distant metastases (DM) for women with initial diagnoses of non-metastatic breast cancer; to estimate breast cancer-specific and overall survival for women with DM. Design: Population-based health record linkage study. Setting, participants: Women diagnosed with localised or regional primary breast cancer recorded in the NSW Cancer Registry, 2001–2002. Major outcome measures: Time from breast cancer diagnosis to first DM, time from first DM to death from breast cancer. Secondary outcome: time to death from any cause. Results: 6338 women were diagnosed with non-metastatic breast cancer (localised, 3885; regional, 2453; median age, 59 years [IQR, 49–69 years]). DM were recorded (to 30 September 2016) for 1432 women (23%; median age, 62 years [IQR, 51–73 years]). The 14-year cumulative DM incidence was 22.2% (95% CI, 21.1–23.2%; localised disease: 14.3% [95% CI, 13.2–15.4%]; regional disease: 34.7% [95% CI, 32.8–36.6%]). Annual hazard of DM was highest during the second year after breast cancer diagnosis (localised disease: 2.8%; 95% CI, 2.3–3.3%; regional disease: 9.1%; 95% CI, 7.8–10.3%); from year five it was about 1% for those with localised disease, from year seven about 2% for women with regional disease at diagnosis. Five years after diagnosis, the 5-year conditional probability of DM was 4.4% (95% CI, 3.7–5.1%) for women with localised and 10.4% (95% CI, 9.1–12.0%) for those with regional disease at diagnosis. Median breast cancer-specific survival from first DM record date was 28 months (95% CI, 25–31 months); the annual hazard of breast cancer death after the first DM record declined from 36% (95% CI, 33–40%) during the first year to 14% (95% CI, 11–18%) during the fourth year since detection. Conclusions: DM risk declines with time from diagnosis of non-metastatic breast cancer, and the annual risk of dying from breast cancer declines with time from initial DM detection. These findings can be used to inform patients at follow-up about changes in risk over time since diagnosis and for planning health services.
- Subject
- breast neoplasms; epidemiology; diagnosis; breast cancer; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1482457
- Identifier
- uon:50933
- Identifier
- ISSN:0025-729X
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 1671
- Visitors: 1667
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|